Chloe Hurling

Chloe is a bioprocessing specialist with a background in translating cell and gene pipelines towards scalable manufacture and clinical application. She spent six years leading iPSC-based allogeneic projects before joining the Cell and Gene Therapy Catapult, where she works on bioprocess strategies to improve the robustness, intensification, and cost-effectiveness of ATMP manufacturing.